Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial

摘要

Background It has been reported that higher levels of oxidative stress and inflammation play a key role in the progression of hepatocellular carcinoma (HCC) after surgery. Coenzyme Q10 is an endogenous lipid-soluble antioxidant. To date, no intervention study has investigated coenzyme Q10 supplementation in HCC patients after surgery. The purpose of this study was to investigate oxidative stress, antioxidant enzymes activity, and inflammation levels in HCC patients after surgery following administration of coenzyme Q10 (300?mg/day). Methods This study was designed as a single-blinded, randomized, parallel, placebo-controlled study. Patients who were diagnosed with primary HCC ( n =?41) and were randomly assign to a placebo ( n =?20) or coenzyme Q10 (300?mg/day, n =?21) group after surgery. The intervention lasted for 12?weeks. Plasma coenzyme Q10, vitamin E, oxidative stress antioxidant enzymes activity and inflammatory markers levels were measured. Results The oxidative stress ( p =?0.04) and inflammatory markers (hs-CRP and IL-6, p ?0.01) levels were significantly decreased, and the antioxidant enzymes activity was significantly increased ( p ?0.01) after 12?weeks of coenzyme Q10 supplementation. In addition, the coenzyme Q10 level was significantly negatively correlated with the oxidative stress ( p =?0.01), and positively correlated with antioxidant enzymes activity (SOD, p =?0.01; CAT, p ?0.05; GPx, p =?0.04) and vitamin E level ( p =?0.01) after supplementation. Conclusion In conclusion, we demonstrated that a dose of 300?mg/d of coenzyme Q10 supplementation significantly increased the antioxidant capacity and reduced the oxidative stress and inflammation levels in HCC patients after surgery. Trial registration Clinical Trials.gov Identifier: NCT01964001